This study aimed to investigate the regulation of HSF1, the possible role of the transcription factor, and to decipher possible downstream targets in the pathogenesis of NAFLD, with regard to the development of the disease. The gene discussed is HSF1; the disease is metabolic dysfunction-associated steatotic liver disease.